Zacks Investment Management Bioventus Inc. Transaction History
Zacks Investment Management
- $11.4 Billion
- Q2 2025
A detailed history of Zacks Investment Management transactions in Bioventus Inc. stock. As of the latest transaction made, Zacks Investment Management holds 56,019 shares of BVS stock, worth $391,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,019Holding current value
$391,012% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BVS
# of Institutions
147Shares Held
49.3MCall Options Held
85.1KPut Options Held
13K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$90.9 Million30.91% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$48.4 Million19.48% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.28MShares$36.9 Million1.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$19.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$16.6 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $430M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...